Home | Welcome to Contract Pharma   
Last Updated Sunday, November 23 2014
Print

Breaking News

January 25, 2012
Profit jumps 12% in the quarter  Read More »
January 25, 2012
Aims to deliver integrated cold chain management solutions  Read More »
January 25, 2012
Expands presence in Asia  Read More »
January 24, 2012
FY Earnings hit by after-tax charges of $4.2 billion  Read More »
January 24, 2012
To pursue a translational research approach  Read More »
January 24, 2012
U.S. patients will return to full Fabrazyme dosing in March  Read More »
January 24, 2012
Buckley and Alp to expand scientific expertise  Read More »
January 24, 2012
Will develop platform for high-density cell cultivation  Read More »
January 23, 2012
Confirms IMP/GMP compliance at Craigavon, Elvingston sites  Read More »
January 23, 2012
UH Bristol provides access to diverse patient populations in key therapeutic areas  Read More »
January 23, 2012
Drouet to lead European Ops  Read More »
January 23, 2012
Maclean brings 20 years of experience  Read More »
January 20, 2012
Will focus on RNAi therapeutic product strategy  Read More »
January 20, 2012
FDA completes review with no 483 citations  Read More »
January 20, 2012
Genzyme will market Veracyte’s Afirma Thyroid FNA Analysis  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On